0000000000489866

AUTHOR

Roque Cardona-hernandez

0000-0002-7067-1657

showing 4 related works from this author

Telemedicine and COVID-19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world-wide cross-sectional web-based survey

2021

Abstract Background Telemedicine for routine care of people with diabetes (PwD) during the COVID‐19 pandemic rapidly increased in many countries, helping to address the several barriers usually seen. Objective This study aimed to describe healthcare professionals' (HCPs) experience on telemedicine use in diabetes care and investigate the changes and challenges associated with its implementation. Methods A cross‐sectional electronic survey was distributed through the global network of JENIOUS members of ISPAD. Respondents' professional and practice profiles, clinic sizes, their country of practice, and data regarding local telemedicine practices during COVID‐19 pandemic were investigated. Re…

AdultMaleTelemedicineClinical Care and TechnologyInternationalityCoronavirus disease 2019 (COVID-19)pediatricstelehealthtype 1 diabetesHealth PersonnelEndocrinology Diabetes and MetabolismTelehealthCOVID‐19Surveys and QuestionnairesGlobal networkPandemicDiabetes MellitusInternal MedicinemedicineHumansData Protection Act 1998PandemicsReimbursementAgedAged 80 and overInternetbusiness.industryCOVID-19Middle Agedmedicine.diseaseWorld wideCross-Sectional StudiesPrivacyPediatrics Perinatology and Child HealthFemalevirtualMedical emergencytelemedicinebusinessPediatric Diabetes
researchProduct

Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pe…

2021

OBJECTIVE Insulin delivery methods, glucose-monitoring modalities, and related outcomes were examined in a large, international, diverse cohort of children and adolescents with type 1 diabetes from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) -Registry. RESEARCH DESIGN AND METHODS Participants with type 1 diabetes of >= 1 year, aged <= 18 years, and who had documented pump or sensor usage during the period August 2017-July 2019 were stratified into four categories: injections-no sensor (referent); injections + sensor; pump-no sensor; and pump + sensor. HbA(1c) and proportion of patients with diabetic ketoacidosis (DKA) or severe hyp…

Insulin pumpKetoacidosisBlood Glucosemedicine.medical_specialtyDiabetic ketoacidosisAdolescentEndocrinology Diabetes and MetabolismDpv030209 endocrinology & metabolismHypoglycemia03 medical and health sciences0302 clinical medicineInsulin Infusion SystemsDiabetes mellitusInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsInsulin030212 general & internal medicineRegistriesChildGlycemicAdvanced and Specialized NursingGlycated HemoglobinType 1 diabetesbusiness.industryBlood Glucose Self-Monitoringmedicine.diseaseQualityHypoglycemiaKetoacidosisDiabetes Mellitus Type 1CohortTherapybusinessDiabetes Care
researchProduct

Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation

2019

The flash glucose monitoring (FGM) system FreeStyle Libre® is a device that measures interstitial glucose in a very simple way and indicates direction and speed of glucose change. This allows persons with diabetes to prevent hypoglycemic and hyperglycemic events. Scientific evidence indicates that the system can improve glycemic control and quality of life. To obtain the maximum benefit, it is necessary to properly handle glucose values and trends. Due to the generalization of the system use, the purpose of the document is to provide recommendations for the optimal use of the device, not only in the management of glucose values and trends but also in the prevention of hypoglycemia, actuati…

Blood Glucosemedicine.medical_specialtyComputer scienceEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringType 2 diabetesHypoglycemiaFlash (photography)Quality of life (healthcare)CommentariesDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinIntensive care medicineRetrospective StudiesGlycemicType 1 diabetesBlood Glucose Self-Monitoringmedicine.diseaseHypoglycemiaDiabetes Mellitus Type 1Quality of LifeInterstitial glucoseJournal of Diabetes Science and Technology
researchProduct

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus

2020

IntroductionCompare cost of the interstitial liquid glucose flash monitoring (FM) system (FreeStyle Libre 2) versus self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes mellitus (T1DM) in Spain.Research design and methodsA model was developed to estimate, with the perspective of the Spanish health system, the annual costs associated with glucose monitoring and hypoglycemic events management in T1DM population, with multiple insulin daily doses (MDI). According to published evidence, rate of severe hypoglycemia (SHE) of 4.90 episodes per patient-year was applied. Reduction of SHE (58.6%) was modeled associated with FM use. Published rates of hospital care (20.2%) and subseq…

Research designAdultBlood Glucosemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismHypoglycemiaBedtimeDiseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineDiabetes mellitusMedicine1867HumansHypoglycemic Agents030212 general & internal medicine1506Epidemiology/Health Services ResearcheducationType 1 diabeteseducation.field_of_studybusiness.industryBlood Glucose Self-Monitoringcost(s)nutritional and metabolic diseasesMonitoring systemmedicine.diseaseRC648-665glucose monitoringDiabetes Mellitus Type 1type 1SpainCohortEmergency medicineadult diabetes cost(s) glucose monitoring type 1adult diabetesbusinessBMJ Open Diabetes Research & Care
researchProduct